Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum94196Research ArticlePrimenenie transdermal'nykh lekarstvennykh form nesteroidnykh protivovospalitel'nykh preparatov u patsientov s poyasnichnoy bol'yuUmarovaKh. Ya-KamchatnovP. R-15092014169858928122021Copyright © 2014, Consilium Medicum2014поясничная больболевой синдромкупированиенестероидные противовоспалительные препаратыпобочные эффектыместная терапиялокальные формы[Mafi J, Mc Carthy E, Davis R, Landon B. Worsening Trends in the Management and Treatment of Back Pain. JAMA Intern Med 2013; 2. doi:10.1001/jamainternmed.2013.8992.][Carnes D, Homer K, Underwood M et al. Pain management for chronic musculoskeletal conditions: the development of an evidence - based and theory - informed pain self - management course. BMJ Open 2013; 3: e003534. doi:10.1136/bmjopen-2013-003534.][Kennedy A, Reeves D, Bower P. The effectiveness and cost effectiveness of a national lay - led self care support programme for patients with long - term conditions: a pragmatic randomised controlled trial. J Epidemiol Community Health 2007; 61: 254-61.][Garcia-Rodriguez L, Hernandez-Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti - inflammatory drugs. Epidemiology 2001; 12: 570-6.][Schaffer D, Florin T, Eagle C et al. Risk of serious NSAID-related gastrointestinal events during long - term exposure: a systematic review MJA 2006; 185 (9): 501-6.][Есин Р.Г., Есин О.Р., Ахмадеева Г.Д., Салихова Г.В. Боль в спине. Казань: Казанский полиграфкомбинат, 2010.][Каратеев А.Е., Новые данные по безопасности НПВП: осложнений меньше, чем мы думали раньше. Неврология и ревматология. Приложение к журналу Cons.Med. 2010; 2: 49-56.][Mc Gettigan P, Henry D. Use of Non-Steroidal Anti - Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low -, Middle -, and High - Income Countries. PLoS Med 2013; 10 (2): e1001388. doi:10.1371/ journal. pmed.1001388.][Fosbol E, Folke F, Jacobsen S et al. Cause - specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circ Cardiovasc Qual Outcomes 2010; 3 (4): 395-405.][Kohli P, Steg P, Cannon C. NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease. Am J Med 2014; 127 (1): 53-60.][Bavry A, Khaliq A, Gong Y, Handberg E. Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. Am J Med 2011; 124 (7): 614-20.][Grosser T, Fries S, Fitz-Gerald G. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006; 116: 4-15.][Brattwall M, Turan I, Jakobsson J. Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004-2008 - a retrospective patient record review. J Pain Res 2010; 3: 131-5.][Batysheva T.T, Otcheskaya O.V, Kamchatnov P.R et al. Efficacy of the Combination of Arthrosan and Combilipen in Patients with Acute Lower Spinal Pain. Neurosci and Behavioral Physiology 2013; 43 (2): 240-3.][Scott N, Moga C, Harstall C. Managing low back pain in the primary care setting: The know - do gap. Pain Res Manage 2010; 15 (6): 392-400.][Smeets L, Moore R, Edwards J et al. Topical NSAIDs for acute pain: a meta - analysis. BMC Fam Pract 2004; 5: 10-6.][Камчатнов П.Р., Чугунов А.В., Трубецкая Е.А. Пациент с болью в спине: возможности терапии. Нервно - мышечные болезни. 2013; 2: 20-7.][Spofford C, Ashmawi H, Subieta A et al. Ketoprofen produces modality - specific inhibition of pain behaviors in rats after plantar incision. Anesth Analg 2009; 109 (6): 1992-9.][Mason L, Moore R, Edwards J et al. Topical NSAIDs for acute pain: a meta - analysis. BMC Fam Pract 2004; 5: 10-6.][Montastier P. Etude de la cinétique de diffusion in vitro de quatre AINS destinés à la voie percutanée. Médicine du sport 1994; 68 (1): 40-4.][Mazieres B. Topical ketoprofen patch. Drugs R D 2005; 6: 337-44.][Gürol Z, Hekimo lu S, Demirdamar R, Sumnu M. Percutaneous absorption of ketoprofen. I. In vitro release and percutaneous absorption of ketoprofen from different ointment bases. Pharm Acta Helv 1996; 71 (3): 205-12.]